SCHEDULE: Sio Capital Boosts Anteris Stake to 8.14%

Sio Capital Management, LLC has reported an 8.14% beneficial ownership stake in Anteris Technologies Global Corp., holding 2,934,027 common shares.

Summary

• Sio Capital Management, LLC reported beneficial ownership of 2,934,027 shares of Anteris Technologies Global Corp. Common Stock.
• This represents 8.14% of the outstanding common stock.
• The percentage is calculated based on 36,062,087 shares of common stock outstanding as of May 13, 2025, as provided in Anteris Technologies Global Corp.'s Form 10-Q filed on May 14, 2025.
• Sio Capital Management, LLC, a registered investment adviser, holds these shares for certain affiliated funds and possesses shared voting and shared dispositive power over them.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Anteris Technologies Global Corp.

Sentiment

Score: 7

Explanation: The filing indicates a significant beneficial ownership stake by Sio Capital Management, LLC, a registered investment adviser, suggesting institutional confidence in Anteris Technologies Global Corp. The acquisition is stated to be in the ordinary course of business, not for control, implying a passive, long-term investment.

Positives

• A significant institutional investor, Sio Capital Management, LLC, has taken a substantial 8.14% stake, indicating potential confidence in Anteris Technologies Global Corp.'s prospects.
• The acquisition of shares was for investment purposes in the ordinary course of business, not for control, suggesting a passive, long-term investment view by a specialized healthcare investment adviser.

Risks

• Sio GP, LLC and Michael Castor, who controls both Sio Capital Management, LLC and Sio GP, LLC, disclaim beneficial ownership of the reported shares, which is a standard legal disclaimer in such filings and not a direct business risk for the issuer.

Future Outlook

This filing is a disclosure of beneficial ownership by an external investment adviser and does not contain any forward-looking statements or guidance from Anteris Technologies Global Corp. regarding its future operations or financial performance.

Industry Context

This filing indicates an institutional investor's interest in Anteris Technologies Global Corp., which operates in the medical technology or biotechnology sector. A significant stake by an investment adviser like Sio Capital Management, LLC, known for its focus on healthcare investments, could signal a positive view on the company's prospects within its industry, potentially attracting further investor attention.

Comparison to Industry Standards

• An 8.14% beneficial ownership stake is a substantial position for an institutional investor in a publicly traded company, often signaling a high level of conviction in the company's long-term value proposition.
• While not directly comparable to operational metrics, such a significant stake by a specialized healthcare fund like Sio Capital Management, LLC, suggests a positive assessment of Anteris Technologies Global Corp. relative to other investment opportunities in the healthcare sector.

Stakeholder Impact

• Shareholders: Increased institutional ownership may be viewed positively by the market, potentially signaling confidence in Anteris Technologies Global Corp. and attracting further investment interest.

Key Dates

Recommendation

The filing indicates a significant institutional stake by Sio Capital Management, LLC, which is generally a positive signal of investor confidence. However, as a Schedule 13G, it primarily discloses ownership and does not provide detailed financial performance, operational updates, or strategic guidance from Anteris Technologies Global Corp. A seasoned investor would view this as a positive indicator of institutional interest but would require further fundamental analysis of the company's financials, pipeline, and market position before making a definitive buy or sell recommendation. Therefore, a 'hold' recommendation is appropriate, pending more comprehensive data.

Keywords

Anteris Technologies, Sio Capital Management, Beneficial Ownership, Common Stock, Investment Adviser, SEC Filing, Schedule 13G, Institutional Investor, Healthcare Investment